- Home
- LEGT vs TARA Comparison
LEGT vs TARA Comparison
Compare LEGT & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.93
Company Overview
Basic Information| Metric | LEGT | TARA |
|---|---|---|
| Founded | 2023 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.6M | 269.8M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | LEGT | TARA |
|---|---|---|
| Price | $9.52 | $3.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $24.40 |
| AVG Volume (30 Days) | 166.7K | ★ 808.7K |
| Earning Date | 02-19-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.25 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,948,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $35.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.13 | $2.77 |
| 52 Week High | $11.94 | $7.82 |
Technical Indicators
Market Signals| Indicator | LEGT | TARA |
|---|---|---|
| Relative Strength Index (RSI) | 34.52 | 35.70 |
| Support Level | N/A | $3.03 |
| Resistance Level | $11.08 | $5.53 |
| Average True Range (ATR) | 0.59 | 0.25 |
| MACD | -0.14 | -0.06 |
| Stochastic Oscillator | 46.03 | 22.30 |
Price Performance
Historical Comparison LEGT
TARA
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.